INS and metabolic syndrome: There are more factors that should be considered when starting insulin therapy: individualized treatment with a dosage and regimen that must be personalized for individual patients; the magnitude of dyslipidemia; glucose concentration as well as overall maternal health; and monitoring of the glucose levels and lipids profiles for adjusting treatment where necessary.